Middle East & Africa Pet Diseases Treatment Market By Disease Type (Infectious Diseases {Bacterial, Viral, Parasitic}, Non-Infectious Diseases {Chronic Diseases, Allergies and Dermatological Issues, Cancer, Cardiovascular Diseases, Endocrine Disorders}, Genetic Disorders), By Treatment Type (Medication {Prescription medications, Over-the-counter medications}, Surgical Interventions, Preventive Care, Alternative Therapies), By Pet Type (Dogs, Cats, Small Mammals, Others), By End-User (Veterinary Hospitals, Veterinary Clinics, Others),,Global Market Size, Segmental analysis, Country Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: May 2025 | Report ID: MI2831 | 219 Pages


Industry Outlook

The Middle East & Africa Pet Diseases Treatment market accounted for USD 1.42 Billion in 2024 and USD 1.52 Billion in 2025 is expected to reach USD 3.06 Billion by 2035, growing at a CAGR of around 7.23% between 2025 and 2035. Treatments in the Middle East & Africa pet diseases market are aimed at managing illnesses found in pets like dogs, cats, and birds. An increase in the adoption of pets, greater awareness of pet health, and more access to veterinary care are fueling the need for disease treatment here. Antibiotics, vaccines, drugs for parasites, and solutions for pain are typical body-care treatments. Early findings and proper treatment are made possible by the market’s access to better diagnostic means.

The UAE and South Africa are developing new veterinary centers, and campaigns focused on prevention are on the rise. Even with these advancements, not all animals can receive specialist vet services, and the treatments for pets can be expensive in certain areas. Many pet owners are turning to holistic and alternative treatments, which reflects new preferences. More efforts by animal welfare groups and the government are shaping how pet healthcare is structured. As pets are treated more like family, the area is moving toward better and easier access to treatments for various pet diseases.

Industry Experts Opinion

“Strengthening veterinary public health systems is essential to control zoonotic diseases and improve pet health outcomes across Africa.”

  • Prof. Olanike Adeyemo, Professor of Veterinary Public Health and Preventive Medicine, University of Ibadan, Nigeria

Report Scope:

ParameterDetails
Largest MarketMEA
Fastest Growing MarketMEA
Base Year2024
Market Size in 2024USD 1.42 Billion
CAGR (2025-2035)7.23%
Forecast Years2025-2035
Historical Data2018-2024
Market Size in 2035USD 3.06 Billion
Countries CoveredTurkey, South Africa, Saudi Arabia, UAE, Egypt, Israel, Nigeria, Algeria, Kenya, Morocco, Rwanda, and Others.
What We CoverMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies
Segments CoveredDisease Type, Treatment Type, Pet Type, End-user, and Country

To explore in-depth analysis in this report - Request Sample Report

 

Market Dynamics

Rising urban pet ownership in cities like Dubai, Riyadh, and Cape Town is increasing demand for veterinary care

More pets belonging to urban residents in Dubai, Riyadh, and Cape Town are primarily driving growth in the Middle East & Africa pet diseases treatment market. With more people moving to cities, having pets is becoming a way to find company, emotional support, and make their lives better. You can notice this change the most among middle- and high-earning populations, who are more interested in pet health care costs.

An increase in pet adoption creates more demand for veterinary care, regular health check-ups, shots, and solutions for handling diseases. Most urban pet owners pay attention to health hazards and are likely to purchase prevention as well as treatment for their pets. Statistics from the Dubai Statistics Center show that more people in the emirate are getting pets, especially dogs and cats, over recent years. In other cities, too, this trend leads to more vets and stores offering pet health items to the market. So, the increase in people owning pets is strongly driving the growth and advancement of the pet disease treatment market there.

Government-led rabies eradication programs in countries like South Africa and Kenya are boosting vaccine usage.

Programs organized by governments in South Africa and Kenya to get rid of rabies are key reasons for the growth in the Middle East & Africa pet diseases treatment market, mainly due to increased need for rabies vaccines. All over the region, rabies is still a major concern for public health, so governments provide widespread inoculations for both community pets and wild animals. The main aim of these initiatives is to cut down the transfer of rabies to humans and enhance the well-being of animals. Schools of thought emphasizing mass immunization have made sure veterinary vaccines are purchased and used more, which has increased the sales of disease prevention products for pets.

As an example, the South African Department of Agriculture has launched national efforts to improve rabies control by making more vaccines reach veterinary clinics and animal shelters than ever before. By doing this, governments increase knowledge about infectious diseases and motivate pet owners to act responsibly, which leads to an increase in the use of many veterinary treatments beyond rabies. Concentrating on ways to prevent disease plays a big role in driving growth in the pet disease treatment market across the region.

A limited number of licensed veterinarians in rural and semi-urban areas restricts access to treatment.

A key challenge for the Middle East & Africa pet diseases treatment market is the shortage of licensed veterinarians in rural and semi-urban areas. In several areas outside major cities, there are not enough skilled veterinary workers, so pets do not receive prompt and good-quality care. Because there are not enough experts, diseases may go undiagnosed or untreated for a longer time, which increases the risk of pets becoming infected.

Many people in such regions often go to unqualified people for their pets’ medications, which may result in pets not receiving the necessary help. Many people in these regions need to travel far to visit a vet, and this is a reason why several pets do not receive regular check-ups. Because rural and semi-urban regions don’t have enough qualified vets, the pet disease treatment market in this region can't grow as fast as it could.

Expansion of local manufacturing of veterinary drugs to reduce costs and improve supply stability.

The growth in local manufacturing of veterinary drugs is an important benefit for the Middle East & Africa pet diseases treatment market. At present, many countries in the region depend heavily on buying veterinary drugs from other nations, which usually makes them more expensive and carries risks for a stable supply. Building local abilities to create medications can bring down the costs and allow more pet owners to afford care. Besides, using local production helps ensure a stable supply by avoiding complications from import rules, shipping issues, or world shortages.

As a result, products specific to the regional health issues and weather can be produced. In many Middle Eastern and African countries, governments are helping to increase pharmaceutical output and encouraging drugmakers to invest. Such actions contribute to market growth as they help ensure that important pet medicines are always available and affordable for all pet owners.

Development of e-commerce platforms for veterinary products and tele-vet consultations.

The development of e-commerce platforms for veterinary products and tele-veterinary consultations is a promising opportunity for the Middle East & Africa pet diseases treatment market. These digital solutions enable pet owners to conveniently access a wide range of medications, supplements, and health products online, overcoming geographical barriers, especially in remote or underserved areas. Tele-vet consultations further enhance access to professional veterinary advice without the need for physical visits, making it easier to diagnose and manage pet diseases promptly.

This convenience is particularly valuable in regions with limited veterinary infrastructure or a shortage of specialists. Additionally, e-commerce platforms can offer competitive pricing and home delivery, encouraging more pet owners to seek timely treatment. As internet penetration and smartphone usage increase in the region, these digital healthcare innovations are set to transform how pet care services are delivered, expanding market reach and improving overall pet health management.

Segment Analysis

Based on the product type, the Middle East & Africa Pet Diseases Treatment Market has been classified into Infectious Diseases, Genetic Disorders, and Non-infectious Diseases. Treatment for infectious diseases is the most active and leading sector within the Middle East & Africa pet diseases market. In places with a warm climate and few regular veterinary appointments, many animals get bacterial, viral, and parasitic diseases, giving a big advantage to parasites. Many pets face rabies, tick-borne ailments, parvovirus, and parasitic infestations, and veterinarians often act rapidly to treat them. More understanding of zoonotic diseases is motivating pet owners and authorities to value vaccinations and early health checks for their pets.

 

Because preventive care is harder to access in rural and semi-urban areas, pets there are more likely to be infected. Governments and non-profit organizations give top priority to fighting infectious diseases since they can risk causing major damage to public health. Therefore, the market is still driven mainly by sales of antibiotics, antivirals, treatment for parasites, and vaccines. As a whole, this trend is part of a big effort to keep pets healthy, fight diseases, and immunize animals throughout the region. 

Based on the product type, the Middle East & Africa Pet Diseases Treatment Market has been classified into Medication, Surgical Interventions, Preventive Care, and Alternative Therapies. The use of medication is the leading and dominant way to treat animals in the Middle East & Africa pet diseases market. In this group, medicines such as prescription and over-the-counter drugs are commonly used to treat pet diseases, particularly the common infectious diseases found in the region.

Pet owners in developing countries choose medications often, since they are easy to get and not too expensive. Many pets are treated with antibiotics, anti-parasitic drugs, and anti-inflammatory medications. When vets in towns can provide prescription drugs, they are widely used. In rural regions, pet owners often pick over-the-counter options. More awareness about pets and how humans treat them is causing more people to use preventive drugs for their animals. The fact that medications are practical, economical, and can be used in various pet diseases makes this area the biggest in veterinary pharmacology.

Regional Analysis

An increase in pet ownership in cities and a new focus on animal welfare are causing the pet disease treatment market in Turkey to steadily grow. More professional veterinary care is available now, thanks to the many new clinics and pet hospitals being opened. To help veterinary clinics exist, animal protection laws have been introduced by the government. Yet, not all rural residents can get advanced treatments as easily as residents in cities. Market demand is supported by creating medicine at home and by importing veterinary drugs. Activities focused on awareness and education appear to be encouraging people to receive care at an earlier stage.

The regional pet healthcare market in South Africa is robust due to a solid network of veterinary practices and increased knowledge about animal diseases. Since tick-borne illnesses and zoonotic diseases can endanger health in the country, people need to take timely preventive actions. Most city pet owners tend to regularly visit a veterinarian and try out new treatments for their pets. Both government bodies and non-profit organizations take action to stop rabies and promote the health of people. Veterinary teaching and research are important activities in South Africa as a regional center. Still, different projects are being carried out to address rural access difficulties.

Rising numbers of pets and more acceptance of having animals as family members are fueling the growth of Saudi Arabia’s pet diseases treatment market. More money is going toward modern veterinary facilities, laboratories, and mobile specialists. Although having livestock was once central to the industry, interest in eating pets is on the rise in Kenya. Regulations related to animal and veterinary drugs are being modified to meet higher standards for care. Many pet owners now look for medication and assistance from across borders and from experts. At present, the market is growing mostly outside important cities like Riyadh and Jeddah.

In the region, the pet disease treatment market in the UAE is both well developed and quickly progressing. High-income households and a large group of expats in the country support the need for better veterinary services. Canada is equipped with advanced clinics, pet wellness centers, and different pet insurance policies. The rules about keeping pets vaccinated and microchipped are regularly checked. People are increasingly trying physiotherapy and holistic treatments, as well as more traditional ways of being treated. The country is leading the advancement in pet health in the Middle East, thanks to its focus on preventive medicine.

Competitive Landscape

A range of international companies and local businesses are helping to grow the Middle East & Africa pet diseases treatment market. The top companies, Zoetis, Elanco, Boehringer Ingelheim, Merck Animal Health, and Virbac, stand out due to having full product lines and effective distribution systems. Firms in this industry are the main suppliers of vaccines, antibiotics, and products that control parasites. Local businesses such as Julphar, Dawa Life Sciences, and Adwya are very important for providing products within poorer or remote parts of the UAE.

Being aware of the demands in each area, they can concentrate on the most common health issues. Competition in the market is high because there are increasing investments in research, local production is rising, and sectors are joining forces to enhance availability. Added intensity in competition is caused by mergers, the launch of new products, and adhering to regulations. With more people understanding the importance of pet health, companies are working hard to keep medical care cost-effective, high-quality quality and available to everyone.

Middle East & Africa Pet Diseases Treatment Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Recent Developments:

  • In February 2025, Boehringer Ingelheim launched its innovative trivalent poultry vaccine, VAXXITEK® HVT+IBD+H5, in Egypt. This vaccine offers comprehensive protection against three major poultry diseases: Marek’s disease, Infectious Bursal Disease (Gumboro), and H5 avian influenza.

Report Coverage:

By Disease Type

  • Infectious Diseases
    • Bacterial
    • Viral
    • Parasitic
  • Non-Infectious Diseases
    • Chronic Diseases
    • Allergies and Dermatological Issues
    • Cancer
    • Cardiovascular Diseases
    • Endocrine Disorders
  • Genetic Disorders

By Treatment Type

  • Medication
    • Prescription medications
    • Over-the-counter medications
  • Surgical Interventions
  • Preventive Care
  • Alternative Therapies

By Pet Type

  • Dogs
  • Cats
  • Small Mammals
  • Others

By End-user

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

By Region

Middle East & Africa

  • Turkey
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel
  • Nigeria
  • Algeria
  • Kenya
  • Morocco
  • Rwanda
  • Oman
  • Qatar
  • Iran
  • Kuwait
  • Rest of Middle East & Africa

List of Companies:

  • Zoetis Inc.
  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck Animal Health (MSD)
  • Virbac Group
  • Ceva Santé Animale
  • Dechra Veterinary Products
  • Vetoquinol SA
  • Hester Biosciences
  • Biogenesis Bagó
  • Julphar
  • Dawa Life Sciences
  • Adwya
  • Aspen Pharmacare
  • United Company for Veterinary Medicines Industry (UNIVET)

Frequently Asked Questions (FAQs)

The Middle East & Africa Pet Diseases Treatment market accounted for USD 1.42 Billion in 2024 and USD 1.52 Billion in 2025 is expected to reach USD 3.06 Billion by 2035, growing at a CAGR of around 7.23% between 2025 and 2035.

Key growth opportunities in the Middle East & Africa Pet Diseases Treatment market include Expansion of local manufacturing of veterinary drugs to reduce costs and improve supply stability, Development of e-commerce platforms for veterinary products and tele-vet consultations, Public-private partnerships to build mobile clinics and rural veterinary centers.

The largest segment is pharmaceuticals; diagnostics is the fastest-growing due to rising demand for advanced pet disease detection and treatment solutions.

South Africa is expected to make a notable contribution due to its developed veterinary infrastructure and rising pet healthcare awareness.

Leading players include Zoetis, Elanco, Boehringer Ingelheim, Merck Animal Health, Virbac, Ceva, Dechra, and regional firms like Julphar and Dawa.


Related Report

Latin America Pet Diseases Treatment Market Size 2025-2035

The Latin America Pet Diseases Treatment market accounted for USD 2.01 billion in 2024 and USD 2.16 billion in 2025 is expected to reach USD 4.36 Billion by 2035, growing at a CAGR of around 7.30% between 2025 and 2035.

Europe Pet Diseases Treatment Market Size & Share 2025-2035

The Europe Pet Diseases Treatment market accounted for USD 4.02 Billion in 2024 and USD 4.32 Billion in 2025 is expected to reach USD 8.92 Billion by 2035, growing at a CAGR of around 7.52% between 2025 and 2035.

North America Pet Diseases Treatment Market Size 2025-2035

The North America Pet Diseases Treatment market accounted for USD 4.50 Billion in 2024 and USD 4.85 Billion in 2025 is expected to reach USD 10.2 Billion by 2035, growing at a CAGR of around 7.7% between 2025 and 2035.

Asia Pacific Pet Disease Treatment Market Size 2025-2035

The Asia Pacific Pet Disease Treatment Market accounted for USD 2.96 Billion in 2024 and USD 3.20 Billion in 2025 is expected to reach USD 7.05 Billion by 2035, growing at a CAGR of around 7.5% between 2025 and 2035.

Pet Diseases Treatment Market Size & Forecast 2025-2035

Pet Diseases Treatment Market sector recorded a valuation of USD 11.85 Billion in 2024 and is poised to expand significantly, hitting USD 26.5 Billion by 2035, driven by a CAGR of 7.60% between 2024 and 2035.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Thank You!

We have received your request for Middle East & Africa Pet Diseases Treatment Market research report. We value your interest in our services and are pleased to inform you that our dedicated research specialist will be reaching out to you shortly. If you have any further questions or require additional assistance, feel free to let us know via-

  [email protected]

To ensure effective communication and prevent spam, we kindly request you to provide your company email address.